Peoples Bancorp Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEBO research report →
Range $42 – $48
Price Chart
About the company
Peoples Bancorp Inc. functions as the parent company for Peoples Bank, delivering an extensive array of commercial and retail banking products and services. The institution provides a variety of deposit options, including demand accounts, savings accounts, money market accounts, and certificates of deposit.
- CEO
- Tyler J. Wilcox
- IPO
- 1993
- Employees
- 1,454
- HQ
- Marietta, OH, US
Get TickerSpark's AI analysis on PEBO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.33B
- P/E
- 10.99
- Fwd P/E
- 9.83
- PEG
- 0.59
- P/S
- 2.18
- P/B
- 1.08
- EV/EBITDA
- 11.99
- Div Yield
- 4.43%
- Gross Margin
- 71.35%
- Op Margin
- 24.80%
- Net Margin
- 19.70%
- ROE
- 10.02%
- ROIC
- 5.54%
Latest fiscal year · YoY change
- Revenue
- $618.38M+0.4%
- Gross Profit
- $417.15M-0.5%
- Op Income
- $134.81M
- Net Income
- $106.78M-8.9%
- EPS
- $3.03-9.3%
- OCF Growth
- -5.9%
- FCF Growth
- -5.6%
- 52W High
- $42.29
- 52W Low
- $27.49
- 50D MA
- $38.09
- 200D MA
- $36.53
- Beta
- 0.61
- RSI (14)
- 39
- Avg Volume
- 385.14K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Peoples Bancorp posted a solid Q3 with better margins, lower provision, and stronger fee income, while management highlighted active merger execution and raised full-year and 2027 growth expectations.· October 20, 2026
- Diluted EPS was $0.91, or $1.04 adjusted for one-time items, versus consensus of $0.93; one-time items included a $4.5 million securities loss and $1.5 million of merger costs.
- Net interest income rose 1% and net interest margin expanded 8 bps in the quarter; fee income increased 5% and provision for credit losses fell 24% to $3.6 million.
- Credit was mixed but manageable: nonperforming loans fell 11%, allowance to loans was 1.11%, and net charge-offs increased to a 35 bps annualized rate.
- The Citizens merger remains on track to close later this month, and management said the Capital Bank deal is now expected to close around the end of Q1 or beginning of Q2 2027.
- 2026 guidance calls for 4.2%-4.3% full-year NIM, $28 million-$30 million of quarterly fee income, $78 million-$80 million of quarterly noninterest expense, and 2%-8% loan growth including Citizens.
For Q3 2026, Peoples reported diluted EPS of $0.91, or $1.04 adjusted for one-time items, topping consensus of $0.93. One-time items included a $4.5 million loss on investment securities, which reduced EPS by $0.10, and $1.5 million of acquisition-related expenses, which reduced EPS by $0.03. Net interest income increased 1% and net interest margin expanded 8 basis points; fee-based income grew 5%; provision for credit losses declined 24% to $3.6 million; and nonperforming loans declined 11%. Return on average assets was 1.36% and return on average stockholders’ equity was 10.44%. For full-year 2026, management expects positive operating leverage, NIM of 4.2%-4.3%, quarterly fee income of $28 million-$30 million, quarterly noninterest expense of $78 million-$80 million, loan growth of 2%-8% including Citizens, and $11 million-$13 million of acquisition-related expenses in Q4. For 2027, excluding the planned capital merger, management expects positive operating leverage, NIM of 4.3%-4.5%, quarterly fee income of $31 million-$33 million, quarterly noninterest expense of $80 million-$82 million in Q2-Q4, and loan growth of 3%-5% versus 2026.
Tyler Wilcox emphasized that the company is in an active strategic phase, focused on closing the Citizens merger and progressing the pending Capital Bank acquisition. He framed both deals as ways to expand market reach, improve products and services, and support future growth beyond the $10 billion asset threshold. His tone was upbeat and confident, but he also stressed disciplined execution, selective lending, and managing asset size through year-end.
Katie Bailey focused on improving core profitability and balance-sheet positioning. She said NII rose 1% and NIM improved 8 bps, helped by higher loan yields and lower deposit costs; for the first nine months, NII was up 5% and deposit interest expense fell nearly $19 million. She also noted the securities sale generated a $4.5 million loss on about $59 million of securities, core deposits were up $19 million, the loan-to-deposit ratio was 91.9%, and all regulatory capital ratios improved, while tangible equity to tangible assets fell because of higher unrealized losses on available-for-sale securities.
Analysts focused on merger timing, loan growth, margin outlook, credit, and expenses. Management said Capital Bank is now expected to close around the end of Q1 or beginning of Q2 2027, and that the Citizens merger should add nearly $350 million of loans and about $550 million of deposits in Q4. On margin, management said Q4 could see an 8 to 10 bps lift from Citizens, and on credit they said commercial credit remains strong, while indirect lending shows some consumer pressure. On expenses, they said Q4 Citizens-related costs should be $11 million-$13 million, and full cost saves from Capital Bank will not be fully realized until 2028.
The call showed clear operational momentum: adjusted EPS beat consensus, NIM expanded, fee income grew, and provision fell. Management also sounded constructive on 2027, citing stronger NIM, renewed small-ticket leasing growth, and continued growth in C&I and CRE as payoffs normalize.
Loan growth was modest in the quarter because of more than $160 million of commercial payoffs, and management still expects another $150 million-$180 million of payoffs in the near term. Credit trends are manageable but not flawless: net charge-offs rose, classified loans increased, and management flagged some pressure in indirect consumer lending. There is also execution risk around integrating two pending mergers while staying under $10 billion in assets and absorbing higher expense and reserve levels over time.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 96.6%
- Shares Outstanding
- 35.96M
- Float Shares
- 34.74M
of shares held by institutions
226 13F filers
Buy/sell ratio 0.20. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for PEBO, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| James Conley Justice, IISenate | Sell | Aug 28, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 3.46M | ▲ 124.78K |
| Dimensional Fund Advisors LP | 2.29M | ▲ 14.47K |
| Vanguard Group Inc | 2.08M | ▲ 48.17K |
| State Street Corp | 2.07M | ▲ 15.79K |
| Vanguard Capital Management LLC | 1.52M | ▼ 11.23K |
| American Century Companies Inc | 1.21M | ▲ 110.11K |
| Geode Capital Management, LLC | 1.08M | ▲ 103.81K |
| Brown Advisory Inc | 816.18K | ▼ 7.03K |
| Invesco Ltd. | 728.72K | ▼ 64.53K |
| Aqr Capital Management LLC | 566.49K | ▲ 83.16K |
| Raymond James Financial Inc | 551.93K | ▼ 14.72K |
| Qube Research & Technologies Ltd | 528.79K | ▲ 441.41K |
Held by 263 ETFs
Biggest fund positions in PEBO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 12, 26 | Kirkham Michael Ryan | sell | 632 |
| Oct 1, 26 | Majka Ron J | other | 1,012 |
| Oct 26, 26 | Smith Dwight Eric | buy | 300 |
| Oct 23, 26 | Augenstein Mark | sell | 2,000 |
| Oct 22, 26 | Donlon Hugh J | sell | 2,650 |
| Oct 2, 26 | Donlon Hugh J | other | 2,350 |
| Sep 30, 26 | Rector Susan D. | other | 1,496 |
| Jun 30, 26 | Rector Susan D. | other | 1,409 |
| Mar 31, 26 | Rector Susan D. | other | 1,618 |
| Sep 30, 26 | Kirkham Michael Ryan | other | 9.646 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PEBO coverage
Recent articles, reports, and earnings notes.
No research on PEBO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PEBO report →Best Value Stocks to Buy for November 20th
zacks.com · Nov 20
New Strong Buy Stocks for November 20th
zacks.com · Nov 20
Peoples Bancorp: The Capital Deal Clears The Regulatory Threshold With Scale, And The Stock Is Cheap
seekingalpha.com · Nov 2
Peoples Bancorp: 3 Key Takeaways for Long-Term Investors
fool.com · Oct 20
Peoples Bancorp Inc. (PEBO) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 20
Peoples Bancorp Q3 Earnings Call Highlights
marketbeat.com · Oct 20
Here's What Key Metrics Tell Us About Peoples Bancorp (PEBO) Q3 Earnings
zacks.com · Oct 20
Peoples Bancorp (PEBO) Q3 Earnings Surpass Estimates
zacks.com · Oct 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.